0093-5385 : 3tc 150 mg / Azt 300 mg Oral Tablet


NDC0093-5385
Labeler: Teva Pharmaceuticals USA Inc
Product Type: Human Prescription Drug
Drug Name: Lamivudine and Zidovudine
Dosage Form: Oral Tablet, Film Coated
Application #: ANDA079081
Rev. Date: 


Appearance:


Markings: TV;TV;L2;L2
Shapes:  Oval
Colors:  White
Size (mm): 17
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

TV TV L2 L2: (0093-5385) 3tc 150 mg / Azt 300 mg Oral Tablet by Teva Pharmaceuticals USA Inc
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0093-5385-06: 60 TABLET, FILM COATED IN 1 BOTTLE (0093‑5385‑06)

Active Ingredients:

  • Lamivudine
  • Zidovudine

Dosage Strength:

  • 150 mg
  • 300 mg

Inactive Ingredients:

  • Hypromellose 2910 (3 Mpa.s)
  • Hypromellose 2910 (6 Mpa.s)
  • Magnesium Stearate
  • Cellulose, Microcrystalline
  • Polyethylene Glycol 400
  • Polysorbate 80
  • Sodium Starch Glycolate Type a Potato
  • Titanium Dioxide

Pharmaceutical Classes:

  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Nucleoside Analog [Chemical/Ingredient]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0378-5180 Lamivudine and Zidovudine Oral Tablet, Film Coated by Mylan Pharmaceuticals Inc.
  • 21695-996 3tc 150 mg / Azt 300 mg Oral Tablet by Rebel Distributors Corp
  • 31722-506 Lamivudine and Zidovudine Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-739 Lamivudine and Zidovudine Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 33342-003 Lamivudine and Zidovudine Oral Tablet by Macleods Pharmaceuticals Limited
  • 42291-363 3tc 150 mg / Azt 300 mg Oral Tablet by Avkare, Inc.
  • 43063-346 3tc 150 mg / Azt 300 mg Oral Tablet by Pd-rx Pharmaceuticals, Inc.
  • 43063-900 Lamivudine and Zidovudine Oral Tablet, Film Coated by Pd-rx Pharmaceuticals, Inc.
  • 49349-896 3tc 150 mg Oral Tablet by Remedyrepack Inc.
  • 50090-1419 Lamivudine and Zidovudine Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-2018 Lamivudine and Zidovudine Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-3920 Lamivudine and Zidovudine Oral Tablet, Film Coated by A-s Medication Solutions
  • 50436-0597 Lamivudine and Zidovudine Oral Tablet, Film Coated by Unit Dose Services
  • 54741-102 Lamivudine and Zidovudine Oral Tablet, Film Coated by Shanghai Desano Bio-pharmaceutical Co., Ltd.
  • 55700-096 Lamivudine and Zidovudine Oral Tablet, Film Coated by Lake Erie Medical Dba Quality Care Products LLC
  • 55700-411 Lamivudine and Zidovudine Oral Tablet by Lake Erie Medical Dba Quality Care Products LLC
  • 57297-284 Lamivudine and Zidovudine Oral Tablet by Lupin Limited
  • 60760-385 3tc 150 mg / Azt 300 mg Oral Tablet by St Marys Medical Park Pharmacy
  • 63629-4872 3tc 150 mg / Azt 300 mg Oral Tablet by Bryant Ranch Prepack
  • 64380-707 Lamivudine and Zidovudine Oral Tablet by Strides Arcolab Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0093-5385 QR Code

< Prev: 0093-5382Next: 0093-5401 >

Related Discussions:

During my Lamivudine/Zidovudine and Efarenz medication, take ginseng?
During my Lamivudine/Zidovudine and Efarenz medication as a HIV patient take Ginseng and other kind of natural supliment...
zidovudine
oral...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA